XML 45 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Tables)
 12 Months Ended
Jun. 30, 2020
Stock Settled Stock Appreciation Rights SARS [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-Based Compensation Grant Details
In 2020, 2019 and 2018, we granted SSSARs to various employees under the terms of the plans. The following table summarizes information relating to these grants:
 
2020
 
2019
 
2018
SSSARs granted
180

 
157

 
185

Weighted average grant date fair value per right
$
24.06

 
$
23.55

 
$
17.85

Weighted average assumptions used in fair value calculations:
 
 
 
 
 
Risk-free interest rate
1.17
%
 
2.43
%
 
2.39
%
Dividend yield
1.81
%
 
1.68
%
 
1.98
%
Volatility factor of the expected market price of our common stock
22.57
%
 
21.77
%
 
22.57
%
Expected life in years
4.01

 
3.04

 
2.85
Compensation Expense And Tax Benefits Recorded
The following table summarizes our SSSARs compensation expense and tax benefits recorded for each of the years ended June 30:
 
2020
 
2019
 
2018
Compensation expense
$
3,049

 
$
3,074

 
$
2,455

Tax benefits
$
640

 
$
646

 
$
690

Intrinsic value of exercises
$
6,693

 
$
6,008

 
$
2,381
Fair Value Of Awards Vested
The total fair values of SSSARs vested for each of the years ended June 30 were as follows:
 
2020
 
2019
 
2018
Fair value of vested rights
$
2,972

 
$
3,143

 
$
2,330
Stock-Settled Stock Appreciation Rights Activity The following table summarizes the activity relating to SSSARs granted under the plans for the year ended June 30, 2020:
 
Number of
Rights
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life in
Years
 
Aggregate
Intrinsic
Value
Outstanding at beginning of year
586

 
$
128.23

 
 
 
 
Exercised
(215
)
 
$
113.89

 
 
 
 
Granted
180

 
$
153.73

 
 
 
 
Forfeited
(12
)
 
$
140.29

 
 
 
 
Outstanding at end of year
539

 
$
142.16

 
3.40
 
$
6,976

Exercisable and vested at end of year
208

 
$
131.21

 
2.39
 
$
4,973

Vested and expected to vest at end of year
511

 
$
143.23

 
3.47
 
$
6,072
Stock-Settled Stock Appreciation Rights Outstanding By Grant Year
The following table summarizes information about the SSSARs outstanding by grant year at June 30, 2020:
 
 
Outstanding
 
Exercisable
 
 
 
 
 
 
Weighted Average
 
 
 
 
Grant Years
 
Range of
Exercise Prices
 
Number
Outstanding
 
Remaining
Contractual
Life in
Years
 
Exercise
Price
 
Number
Exercisable
 
Weighted
Average
Exercise
Price
2020
 
$153.71-$154.44
 
180
 
4.64
 
$153.73
 
—
 
$—
2019
 
$148.18-$180.60
 
148
 
3.67
 
$154.62
 
48
 
$154.63
2018
 
$117.76-$124.29
 
126
 
2.65
 
$121.12
 
75
 
$121.15
2017
 
$121.54-$138.96
 
66
 
1.66
 
$134.27
 
66
 
$134.27
2016
 
$101.70
 
19
 
0.65
 
$101.70
 
19
 
$101.70
Employee Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-Based Compensation Grant Details
In 2020, 2019 and 2018, we granted shares of restricted stock to various employees under the terms of the plans. The following table summarizes information relating to these grants:
 
2020
 
2019
 
2018
Employees
 
 
 
 
 
Restricted stock granted
31

 
13

 
27

Grant date fair value
$
4,813

 
$
2,030

 
$
3,218

Weighted average grant date fair value per award
$
153.72

 
$
154.66

 
$
121.09
Director Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-Based Compensation Grant Details
In 2020, 2019 and 2018, we also granted shares of restricted stock to our nonemployee directors under the terms of the plans. The following table summarizes information relating to each of these grants:
 
2020
 
2019
 
2018
Nonemployee directors
 
 
 
 
 
Restricted stock granted
5

 
4

 
6

Grant date fair value
$
760

 
$
760

 
$
759

Weighted average grant date fair value per award
$
155.70

 
$
180.16

 
$
123.11
Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Compensation Expense And Tax Benefits Recorded
The following table summarizes our restricted stock compensation expense and tax benefits recorded for each of the years ended June 30:
 
2020
 
2019
 
2018
Compensation expense
$
3,066

 
$
2,898

 
$
2,584

Tax benefits
$
644

 
$
609

 
$
726
Fair Value Of Awards Vested
The total fair values of restricted stock vested for each of the years ended June 30 were as follows:
 
2020
 
2019
 
2018
Fair value of vested shares
$
2,284

 
$
3,537

 
$
1,508
Restricted Stock Activity
The following table summarizes the activity relating to restricted stock granted under the plans for the year ended June 30, 2020:
 
Number of
Shares
 
Weighted
Average Grant
Date Fair Value
Unvested restricted stock at beginning of year
51

 
$
137.17

Granted
36

 
$
153.99

Vested
(16
)
 
$
145.28

Forfeited
(2
)
 
$
133.79

Unvested restricted stock at end of year
69

 
$
144.27